Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anne Larrouy"'
Autor:
Cecile Le Pechoux, Nicolas Pourel, Fabrice Barlesi, Delphine Lerouge, Delphine Antoni, Bruno Lamezec, Ursula Nestle, Pierre Boisselier, Eric Dansin, Amaury Paumier, Karine Peignaux, François Thillays, Gerard Zalcman, Jeannick Madelaine, Eric Pichon, Anne Larrouy, Armelle Lavole, Delphine Argo-Leignel, Marc Derollez, Corinne Faivre-Finn, Matthew Q Hatton, Oliver Riesterer, Emilie Bouvier-Morel, Ariane Dunant, John G Edwards, Pascal Alexandre Thomas, Olaf Mercier, Aurelie Bardet
Publikováno v:
The Lancet Oncology. 23:104-114
Autor:
Cecile, Le Pechoux, Nicolas, Pourel, Fabrice, Barlesi, Delphine, Lerouge, Delphine, Antoni, Bruno, Lamezec, Ursula, Nestle, Pierre, Boisselier, Eric, Dansin, Amaury, Paumier, Karine, Peignaux, François, Thillays, Gerard, Zalcman, Jeannick, Madelaine, Eric, Pichon, Anne, Larrouy, Armelle, Lavole, Delphine, Argo-Leignel, Marc, Derollez, Corinne, Faivre-Finn, Matthew Q, Hatton, Oliver, Riesterer, Emilie, Bouvier-Morel, Ariane, Dunant, John G, Edwards, Pascal Alexandre, Thomas, Olaf, Mercier, Aurelie, Bardet
Publikováno v:
The Lancet. Oncology. 23(1)
In patients with non-small-cell lung cancer (NSCLC), the use of postoperative radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis showing a deleterious effect on survival in patients with pN0 and pN1, but with an uncle
Autor:
Isabelle Colombet, Marie-Laure Alby, Nathalie Nisenbaum, Luc Garcon, Elisabeth Destaintot, groupe soins palliatifs en cancérologie de l’ARS d’Île-de-France, Elisabeth Balladur, Julie Giroux, Idriss Farota-Romejko, Sarah Dauchy, Pascale Vinant, François Goldwasser, Isabelle Marin, Anne Larrouy, Danièle Legrand
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (5), pp.458-464. ⟨10.1016/j.bulcan.2018.01.017⟩
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (5), pp.458-464. ⟨10.1016/j.bulcan.2018.01.017⟩
International audience; Progress leads to increase life duration at the metastatic stage but metastatic disease is most often lethal. Decision-making is necessary for an increasing period of care, beyond evidence-based medicine, dealing with complexi
Autor:
Gaetan Des Guetz, Jean F. Morere, Anne Larrouy, Thierry Landre, Laurent Quero, Yves Panis, Muriel Mathonnet
Publikováno v:
Journal of Clinical Oncology. 38:4098-4098
4098 Background: Neoadjuvant fluoropyrimidine (5FU or capecitabine)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition of oxaliplatin (OXP) will further improve clinical
Autor:
François, Goldwasser, Nathalie, Nisenbaum, Pascale, Vinant, Elisabeth, Balladur, Sarah, Dauchy, Idriss, Farota-Romejko, Isabelle, Colombet, Marie-Laure, Alby, Julie, Giroux, Anne, Larrouy, Elisabeth, Destaintot, Luc, Garcon, Danièle, Legrand, Isabelle, Marin
Publikováno v:
Bulletin du cancer. 105(5)
Progress leads to increase life duration at the metastatic stage but metastatic disease is most often lethal. Decision-making is necessary for an increasing period of care, beyond evidence-based medicine, dealing with complexity and uncertain benefit
Autor:
Jean-Marc Cosset, Jean-Claude Rosenwald, Martine Antoine, Bernard Milleron, Patrice Callard, Emmanuel Touboul, Martin Housset, Anne Larrouy, Philippe Giraud, Marie-France Carette, Yann De Rycke
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 48:1015-1024
Purpose: One of the most difficult steps of the three-dimensional conformal radiotherapy (3DCRT) is to define the clinical target volume (CTV) according to the degree of local microscopic extension (ME). In this study, we tried to quantify this ME in
Publikováno v:
La Revue du praticien. 53(20)
For the last 10 years, along with surgery, radiotherapy has become a major issue in the curative treatment of prostate cancer. Several radiotherapy techniques can be used. In good prognosis cancers, when the prostate is small, brachytherapy is one of